Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-13 | 2023-10-04 | 198602 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2023-07-18 | 2023-07-21 | 198957 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 198960 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-07-18 | 2023-10-06 | 199015 |
TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2023-07-18 | 2023-08-18 | 199026 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 199053 |
TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-07-18 | 2024-03-18 | 199092 |
TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 10MG | TABLET | Resolved | 2023-07-18 | 2023-10-03 | 199103 |
ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-18 | 2023-10-05 | 199106 |
TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2023-07-19 | 2023-08-04 | 199190 |
TEVA-DILTIAZEM XC | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-19 | 2023-12-14 | 199199 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-20 | 2023-10-03 | 199284 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-20 | 2023-07-28 | 199306 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-07-20 | 2023-10-04 | 199313 |
TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2023-07-20 | 2023-10-04 | 199345 |
TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2023-07-20 | 2023-10-05 | 199360 |
TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2023-07-20 | 2023-10-04 | 199387 |
ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-20 | 2023-10-06 | 199390 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-07-20 | 2024-04-25 | 199393 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-20 | 2024-01-19 | 199398 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |